| 1. |
胡湘蜀, 张玮, 郭强, 等.药物难治性脑炎后颞叶癫痫的定位诊断及外科治疗——立体定向脑电图的临床分析.癫痫杂志, 2016, 2(4): 296-307.
|
| 2. |
Kukhanova MK, Korovina AN, Kochetkov SN. Human herpes simplex virus: life cycle and development of inhibitors. Biochemistry (Mosc), 2014, 79(13): 1635-1652.
|
| 3. |
Agut H, Bonnafous P, Gautheret-Dejean A. Human herpesviruses 6A, 6B, and 7. MicrobiolSpectr, 2016, 4(3): 157-158.
|
| 4. |
Tesini BL, Epstein LG, Caserta MT. Clinical impact of primary infection with roseoloviruses. CurrOpinVirol, 2014, 9(6): 91-96.
|
| 5. |
Zhang E, BellAJ, WilkieGS, et al.Inherited chromosomally integrated human herpesvirus 6 genomes are ancient, intact and potentially able to reactivate from telomeres.J Virol, 2017. [Epub ahead of print].
|
| 6. |
Correa Sierra CB, KouriCardella V, Perez Santos L, et al. Herpesviruses excretion in saliva of pediatric transplant recipients. Transpl Infect Dis, 2017. [Epub ahead of print].
|
| 7. |
Quintela A, Escuret V, Roux S, et al. HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns. J Infect, 2016, 72(2): 214-222.
|
| 8. |
Phan TL, Lautenschlager I, Razonable RR, et al. HHV-6 in liver transplantation: A literature review. Liver Int, 2017. [Epub ahead of print].
|
| 9. |
Pantry, SN, MedveczkyPG. Latency, integration, and reactivation of human herpesvirus-6. Viruses, 2017, 9(7): 194-205.
|
| 10. |
Marci R, Gentili V, Bortolotti D, et al. Presence of HHV-6A in endometrial epithelial cells from women with primary unexplained infertility. PLoS One, 2016, 11(7): e0158304.
|
| 11. |
Zerr DM, Meier AS, Selke SS, et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med, 2005, 352(8): 768-776.
|
| 12. |
Racicot K, Mor G. Risks associated with viral infections during pregnancy. J Clin Invest, 2017, 127(5): 1591-1599.
|
| 13. |
Reddy S, Eliassen E, Krueger GR.Human herpesvirus 6-induced inflammatorycardiomyopathy in immunocompetent children.Ann PediatrCardiol, 2017, 10(3): 259-268.
|
| 14. |
Zhao J, Chen Y, Xu Y, et al. Effect of intrauterine infection on brain development and injury. Int J DevNeurosci, 2013, 31(7): 543-549.
|
| 15. |
Caserta MT, Hall CB, Canfield RL, et al. Early developmental outcomes of children with congenital HHV-6 infection. Pediatrics, 2014, 134(6): 1111-1118.
|
| 16. |
Millichap JJ, Millichap JG. Role of HHV-6B infection in mesial temporal lobe epilepsy. PediatrNeurol Briefs, 2015, 29(5): 40.
|
| 17. |
Donati D, Akhyani N, Fogdell-Hahn A, et al. Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology, 2003, 61(10): 1405-1411.
|
| 18. |
Kawamura Y, Nakayama A, Kato T, et al. Pathogenic role of human herpesvirus6B infection in mesial temporal lobe epilepsy. J Infect Dis, 2015, 212(7): 1014-1021.
|
| 19. |
He J, Mc Carthy M, Zhou Y, et al.Infection of primary human fetal astrocytes by human herpesvirus 6.J Virol, 1996, 70(2): 1296-1300.
|
| 20. |
Ahlqvist J, Fotheringham J, Akhyani N, et al.Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes.J Neurovirol, 2005, 11(4):384-394.
|
| 21. |
Heuser K, Szokol K, Tauboll E. The role of glial cells in epilepsy. Tidsskr Nor Laegeforen, 2014, 134(1): 37-41.
|
| 22. |
Fotheringham J, Williams EL, Akhyani N.Human herpesvirus 6 (HHV-6) induces dysregulation of glutamate uptake and transporter expression in astrocytes.J Neuroimmune Pharmacol, 2008, 3(2):105-116.
|
| 23. |
Qian F, TangFR. Metabotropic glutamate receptors and interacting proteins in epileptogenesis. Curr Neuropharmacol, 2016, 14(5): 551-562.
|
| 24. |
Hu X, Wang JY, Gu R, et al.The relationship between the occurrence of intractable epilepsy with glial cells and myelin sheath-an experimental study.Eur Rev Med PharmacolSci, 2016, 20(21): 4516-4524.
|
| 25. |
Campbell A, Hogestyn JM, Folts CJ, et al.Expression of the human herpesvirus 6A latency-associated transcript U94A disrupts human oligodendrocyte progenitor migration.Sci Rep, 2017, 7(1):3978.
|
| 26. |
Agut H, BonnafousP, Gautheret-DejeanA. Laboratory and clinical aspects of human herpesvirus 6 infections. ClinMicrobiol Rev, 2015, 28(2): 313-335.
|
| 27. |
Hill JA, Boeckh M, Leisenring WM, et al.Human herpesvirus 6B reactivation and delirium are frequent and associated events after cord blood transplantation.Bone Marrow Transplant, 2015, 50(10): 1348-1351.
|
| 28. |
Yamamoto S, Takahashi S, Tanaka R, et al.Human herpesvirus-6 infection-associated acute encephalopathy without skin rash.Brain Dev, 2015, 37(8): 829-832.
|
| 29. |
Ogata M, Satou T, Inoue Y, et al.Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis.Bone Marrow Transplant, 2013, 48(2): 257-264.
|
| 30. |
Flamand L, Komaroff AL, Arbuckle JH, et al.Review, part 1: Human herpesvirus-6-basic biology, diagnostic testing, and antiviral efficacy. J Med Virol, 2010, 82(9): 1560-1568.
|
| 31. |
Mardivirin L, Descamps V, Lacroix A, et al.Early effects of drugs responsible for DRESS on HHV-6 replication in vitro.J ClinVirol, 2009, 46(3): 300-302.
|
| 32. |
Hakacova N, Klingel K, Kandolf R, et al.First therapeutic use of Artesunate in treatment of human herpesvirus 6B myocarditis in A child.J ClinVirol, 2013, 57(2): 157-160.
|
| 33. |
Reddy S, Eliassen E, Krueger GR.Human herpesvirus 6-induced inflammatory cardiomyopathy in immunocom petent children.Ann Pediatr Cardiol, 2017, 10(3): 259-268.
|
